Terms: = Breast cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
1529 results:
1. pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.
Inakami K; Fujita N; Iguchi C; Enomoto Y; Minohata J; Sata A; Miyagawa Y; Yanagisawa T; Saitoh T; Nomura T; Sawai Y; Takahara K; Kasugai T; Shiba E
J Med Case Rep; 2024 May; 18(1):214. PubMed ID: 38689362
[TBL] [Abstract] [Full Text] [Related]
2. Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer.
Kawano T; Englisch C; Hisada Y; Paul D; Archibald S; Grover S; Pabinger I; Ay C; Mackman N
Thromb Res; 2024 May; 237():23-30. PubMed ID: 38547690
[TBL] [Abstract] [Full Text] [Related]
3. Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer.
Esmaeili Y; Dabiri A; Mashayekhi F; Rahimmanesh I; Bidram E; Karbasi S; Rafienia M; Javanmard SH; Ertas YN; Zarrabi A; Shariati L
Biomed Pharmacother; 2024 Apr; 173():116465. PubMed ID: 38507955
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of muc1-targeted CAR-NK cells against human tongue squamous cell carcinoma.
Lin X; Guan T; Li Y; Lin Y; Huang G; Lin Y; Sun P; Li C; Gu J; Zeng H; Ma C
Front Immunol; 2024; 15():1337557. PubMed ID: 38390321
[TBL] [Abstract] [Full Text] [Related]
5. Surface-enhanced Raman spectroscopy of the filtrate portions of the blood serum samples of breast cancer patients obtained by using 30 kDa filtration device.
Hajab H; Anwar A; Nawaz H; Majeed MI; Alwadie N; Shabbir S; Amber A; Jilani MI; Nargis HF; Zohaib M; Ismail S; Kamal A; Imran M
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Apr; 311():124046. PubMed ID: 38364514
[TBL] [Abstract] [Full Text] [Related]
6. GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-muc1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies.
Gellert J; Jäkel A; Danielczyk A; Goletz C; Lischke T; Flechner A; Dix L; Günzl A; Kehler P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338686
[TBL] [Abstract] [Full Text] [Related]
7. breast cancer Detection Using a Low-Dose Positron Emission Digital Mammography System.
Freitas V; Li X; Scaranelo A; Au F; Kulkarni S; Ghai S; Taeb S; Bubon O; Baldassi B; Komarov B; Parker S; Macsemchuk CA; Waterston M; Olsen KO; Reznik A
Radiol Imaging Cancer; 2024 Mar; 6(2):e230020. PubMed ID: 38334470
[TBL] [Abstract] [Full Text] [Related]
8. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
[TBL] [Abstract] [Full Text] [Related]
9. Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union.
Wyrwicz L; Rodríguez Sánchez CA; Sánchez-Rovira P; Lewis S; Sandschafer D; San T
Future Oncol; 2024 Apr; 20(13):821-832. PubMed ID: 38305004
[TBL] [Abstract] [Full Text] [Related]
10.
Treven P; Paveljšek D; Kostanjšek R; Golob M; Bogovič Matijašič B; Mohar Lorbeg P
Microbiol Spectr; 2024 Mar; 12(3):e0236923. PubMed ID: 38289112
[TBL] [Abstract] [Full Text] [Related]
11. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer.
Cherifi F; Da Silva A; Martins-Branco D; Awada A; Nader-Marta G
Expert Opin Drug Metab Toxicol; 2024; 20(1-2):45-59. PubMed ID: 38214896
[TBL] [Abstract] [Full Text] [Related]
13. Methylthioadenosine Phosphorylase and breast cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.
Chen Y; Du X; Gao Y; Wu H; Zhao H; Su Y
Cancer Control; 2023; 30():10732748231220805. PubMed ID: 38092371
[TBL] [Abstract] [Full Text] [Related]
14. Advances in breast PET Instrumentation.
Krishnamoorthy S; Surti S
PET Clin; 2024 Jan; 19(1):37-47. PubMed ID: 37949606
[TBL] [Abstract] [Full Text] [Related]
15. CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects.
Wekking D; Leoni VP; Lambertini M; Dessì M; Pretta A; Cadoni A; Atzori L; Scartozzi M; Solinas C
Cytokine Growth Factor Rev; 2024 Feb; 75():57-64. PubMed ID: 37838584
[TBL] [Abstract] [Full Text] [Related]
16. The Therapeutic Effects of muc1-C shRNA@Fe
Li Z; Guo T; Zhao S; Lin M
Int J Nanomedicine; 2023; 18():5651-5670. PubMed ID: 37822991
[TBL] [Abstract] [Full Text] [Related]
17. Selective inhibition of indoleamine and tryptophan 2,3-dioxygenases: Comparative study on kynurenine pathway in cell lines via LC-MS/MS-based targeted metabolomics.
Villani S; Fallarini S; Rezzi SJ; Di Martino RMC; Aprile S; Del Grosso E
J Pharm Biomed Anal; 2024 Jan; 237():115750. PubMed ID: 37804639
[TBL] [Abstract] [Full Text] [Related]
18. Single Cell Phenotypic Analysis for cancer Stem Cell Identification by Dual-Isotope ICP-QMS.
Liu M; Wei X; Wu C; Liu J; Wei Y; Wang X; Chen ML; Yang T; Wang JH
Anal Chem; 2023 Sep; 95(38):14447-14454. PubMed ID: 37695163
[TBL] [Abstract] [Full Text] [Related]
19. Superficial desmoplastic fibroblastoma (collagenous fibroma): Clinicopathologic study of 11 cases.
Bakhshwin A; Oaxaca G; Armstrong S; Ko J; Billings S
J Cutan Pathol; 2024 Jan; 51(1):70-75. PubMed ID: 37666661
[TBL] [Abstract] [Full Text] [Related]
20. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal cancer and Invasive breast cancer.
Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
[TBL] [Abstract] [Full Text] [Related]
[Next]
